Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526
Diabetes Tips, News & Articles
We were interested by the recent article from Gange et al. (1), who reported that 1.74% of 71,817 individuals with newly diagnosed type 2 diabetes had a proliferative retinopathy 5 years later. The authors mentioned that this incidence was probably underestimated because the patients were not mandated to follow-up at strict intervals, which prompted us to analyze how many of our patients with recent (≤5-year duration) type 2 diabetes had a sight-threatening retinopathy.
Note: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online
We were interested by the recent article from Gange et al. (1), who reported that 1.74% of 71,817 individuals with newly diagnosed type 2 diabetes had a proliferative retinopathy 5 years later. The authors mentioned that this incidence was probably underestimated because the patients were not mandated to follow-up at strict intervals, which prompted us to analyze how many of our patients with recent (≤5-year duration) type 2 diabetes had a sight-threatening retinopathy.
We were interested by the recent article from Gange et al. (1), who reported that 1.74% of 71,817 individuals with newly diagnosed type 2 diabetes had a proliferative retinopathy 5 years later. The authors mentioned that this incidence was probably underestimated because the patients were not mandated to follow-up at strict intervals, which prompted us to analyze how many of our patients with recent (≤5-year duration) type 2 diabetes had a sight-threatening retinopathy.
Read moreNote: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online